GRM5 and Anxiety: A number of studies have implicated metabotropic glutamate subtype 5 receptors (mGluR5) in FXS4; the use of mGluR5 antagonists in Fmr1 Knockout (KO) mouse models has demonstrated a variety of benefits including reduced seizures, anxiety, and behavioral issues5,6.